Pilepich, Miljenko V.
Ronald Reagan UCLA Medical Center,
United States
2025 Rank: 133769
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 5019 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 133769 | 152798 |
| Total Cites | 8013 | 8524 |
| H-index | 43 | 44 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 3319 | 3481 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 4878 | 5091 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5306 | 5516 |
| Ratio of Total Citations to Distinct Citing Papers | 1.51 | 1.55 |
| Self-Citation Percentage |
5.99%
|
|
Pilepich, Miljenko V.
Ronald Reagan UCLA Medical Center,
United States
2024 Rank: 122763
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 4714 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 122763 | 140329 |
| Total Cites | 7930 | 8438 |
| H-index | 43 | 44 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 3288 | 3450 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 4825 | 5037 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5227 | 5434 |
| Ratio of Total Citations to Distinct Citing Papers | 1.52 | 1.55 |
| Self-Citation Percentage |
6.02%
|
|
Pilepich, Miljenko V.
Ronald Reagan UCLA Medical Center,
United States
2023 Rank: 117436
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 4564 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 117436 | 133155 |
| Total Cites | 7793 | 8298 |
| H-index | 42 | 44 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 3238 | 3399 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 4751 | 4962 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5115 | 5319 |
| Ratio of Total Citations to Distinct Citing Papers | 1.52 | 1.56 |
| Self-Citation Percentage |
6.09%
|
|
Pilepich, Miljenko V.
Ronald Reagan UCLA Medical Center,
United States
2022 Rank: 108169
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 4243 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 108169 | 124332 |
| Total Cites | 7548 | 8029 |
| H-index | 41 | 42 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 3154 | 3315 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 4609 | 4816 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4944 | 5144 |
| Ratio of Total Citations to Distinct Citing Papers | 1.53 | 1.56 |
| Self-Citation Percentage |
5.99%
|
|
Pilepich, Miljenko V.
Ronald Reagan UCLA Medical Center,
United States
2021 Rank: 102813
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 4067 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 102813 | 118348 |
| Total Cites | 7367 | 7842 |
| H-index | 41 | 42 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 3084 | 3242 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 4502 | 4705 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4815 | 5011 |
| Ratio of Total Citations to Distinct Citing Papers | 1.53 | 1.56 |
| Self-Citation Percentage |
6.06%
|
|
Pilepich, Miljenko V.
Ronald Reagan UCLA Medical Center,
United States
2020 Rank: 88998
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 3725 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 88998 | 101191 |
| Total Cites | 7349 | 7873 |
| H-index | 41 | 43 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 3026 | 3196 |
| Number of Single+First+Last Authored Papers | 65 | 65 |
| Total Cites to Single+First+Last Authored Papers | 4423 | 4647 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4744 | 4960 |
| Ratio of Total Citations to Distinct Citing Papers | 1.55 | 1.59 |
| Self-Citation Percentage |
6.66%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.